89bio, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol: ETNB on Nasdaq
Industry: Pharmaceutical Preparations
Location: 655 Montgomery Street, Suite 1500, San Francisco, CA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	3	+9M	99.4%	$8.65	+$77.9M
Sells	1	-54.2K	0.6%	$7.18	-$389K
Net	+2	+8.95M	98.8%		+$77.5M

89bio, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Ra Capital Management, L.P.	Director, 10%+ Owner	$208M	+$77.6M	+59.6%	Feb 3, 2025
Orbimed Advisors Llc	10%+ Owner	$21.1M			Jan 25, 2022
Rohan Palekar	Chief Executive Officer, Director	$9.11M	+$123K	+1.37%	Feb 17, 2025
Harry H. Mansbach	Chief Medical Officer	$3.37M			Feb 17, 2025
Ryan Martins	Chief Financial Officer	$2.85M			Feb 17, 2025
Quoc Le-Nguyen	Chief Technical Operations Officer	$2.04M	-$389K	-16%	Apr 15, 2025
Francis Willard Sarena	Chief Operating Officer	$689K			Feb 1, 2025
Charles McWherter	Director	$168K	+$180K		Feb 3, 2025
Ram Waisbourd	Chief Operating Officer and Chief Business Officer	$101K			Feb 17, 2022
Steven Altschuler	Director				Feb 3, 2025
Derek DiRocco	Director				Feb 3, 2025
Edward Morrow Atkinson III	Director				Feb 3, 2025
Kathleen Laporte	Director				Feb 3, 2025
Martin Babler	Director				Feb 3, 2025
Michael R. Hayden	Director				Feb 3, 2025
Lota S. Zoth	Director				Feb 3, 2025
Gregory Grunberg	Director, 10%+ Owner				Feb 9, 2023

Recent Insider Transactions by Companies or Individuals for 89bio, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.